This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Heartfailure (HF) is a significant problem in the UK with variation in services across the country. Seventy-nine responses describing hospital-based HF services from all devolved countries were received. The clinical lead in 82% of hospitals was a cardiologist with specialist interest in HF. and 75%, respectively.
In partnership with Abbott, the American Heart Association has launched a $3 million initiative to address knowledge gaps found within heartfailure treatment education that may be contributing to cardiovascular care disparities.
People hospitalized for infectionsalmost any infectionsare at substantially increased risk years later for heartfailure, according to collaborative research by the University of Minnesota and Mayo Clinic.
mtaschetta-millane Wed, 07/31/2024 - 06:00 July 31, 2024 — A novel study co-authored by a heartfailure cardiologist at University Hospitals Harrington Heart & Vascular Institute, demonstrates the effectiveness of a newly developed scoring system in identifying patients with HeartFailure with Preserved Ejection Fraction (HFpEF).
a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heartfailure monitoring detected twice as many heartfailure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.
BackgroundHeart failure (HF), a global health challenge, is a leading cause of mortality in hospitalized patients. The association between ACC and clinical outcomes in HF patients was analyzed using Cox proportional hazards regression and restricted cubic spline models.ResultsA total of 4,737 heartfailure patients were included.
(‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heartfailure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: HeartFailure. Heartfailure (HF) is a leading cause of hospitalization in the United States.
A team at Allina Health’s Abbott Northwestern Hospital has successfully completed the first Barostim Baroreflex Activation Therapy implant in the state of Minnesota, according to an announcement from CVRx, Inc. and Allina Health. and Allina Health. and Allina Health. The Minneapolis, MN-based company received U.S.
In adults with congenital heart disease (ACHD patients), atrial arrhythmias (AA) and heartfailure (HF) are common. Of these, AA is one of the leading causes for hospital admissions in ACHD care.
This secondary analysis of the Safety, Tolerability, and Efficacy of Rapid Optimization, Helped by N-Terminal Pro–Brain Natriuretic Peptide Testing of HeartFailure Therapies (STRONG-HF) randomized clinical trial investigates what variables are associated with success in uptitration of guideline-directed medical therapy after hospital discharge for (..)
A novel study co-authored by a heartfailure cardiologist at University Hospitals Harrington Heart & Vascular Institute demonstrates the effectiveness of a newly developed scoring system in identifying patients with HeartFailure with Preserved Ejection Fraction (HFpEF).
Background Iron deficiency (ID) is a highly prevalent comorbidity in patients with chronic and acute heartfailure and is associated with worse clinical outcomes. We aimed to evaluate the prevalence and clinical characteristics of ID and its association with in-hospital congestion and postdischarge outcomes.
Veraprapas Kittipibul, MD, discusses a study examining costs associated with heartfailurehospitalization among patients with HFrEF or HFpEF from within the GWTG-HF registry.
based UMass Memorial Health-Harrington Hospital reduced the all-cause 30-day readmission for heartfailure patients by 50% as part of a remote patient monitoring program with digital health company Brook Health. Southbridge, Mass.-based
Of those, 97 hospitals were recognized for delivering superior clinical outcomes in cardiac care for heart bypass surgery, coronary interventional procedures, heart attack treatment, heartfailure treatment and heart valve surgery. Healthgrades published its 2025 Specialty Excellence Awards recipients Oct.
RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heartfailure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. Atlanta, GA.
Background Early prediction of heartfailure (HF) after acute myocardial infarction (AMI) is essential for personalized treatment. The primary endpoint was the occurrence of HF within 3 years after operation.
recently announced that Digitiva, a non-invasive digital health solution for heartfailure management, has been listed with the U.S. a smartphone app designed for heartfailure patients and built on the Welldoc, Inc. tim.hodson Thu, 09/19/2024 - 09:42 Sept. 18, 2024 – Astellas Pharma Inc.
milla1cf Mon, 02/26/2024 - 12:40 February 26, 2024 — More than 6 million Americans live with heartfailure , and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. Patients may experience trouble breathing and fatigue, and at times require hospitalization.
Baseline characteristics for the vericiguat global study in participants with chronic heartfailure (VICTOR) trial. of participants had no prior hospitalization for heartfailure. Conclusion The VICTOR trial enrolled the most optimally treated population in a phase III heartfailure trial.
Association of clonal haematopoiesis with heartfailure incidence and outcomes: A systematic review and meta-analysis. Clonal haematopoiesis and heartfailure: a meta-analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heartfailure.
Matthew Segar co-authored a study in JACC HeartFailure led by his research and residency mentor, University of Texas Southwestern Medical Center's Dr. Ambarish Pandey , that utilized a machine learning-based-approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heartfailure (ADHF).
The FDA has approved an artificial intelligence algorithm for Eko Health's digital stethoscope that can detect low ejection fraction, a key indicator of heartfailure.
Patients with heartfailure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a range of physical and psychological symptoms, including shortness of breath, chest discomfort, fatigue, fluid congestion, trouble with sleeping, and depression.
Lower levels of selenoprotein P were associated with reduced hemoglobin, greater transferrin receptor 1, and an increased prevalence of anemia in a cohort of hospitalizedheartfailure patients.
Discover the top 10 hospitals with the highest excess readmission rates for heartfailure patients, according to CMS' hospital readmissions reduction program
announced that the peer-reviewed Journal of the American College of Cardiology: HeartFailure has published a research paper concluding that INPEFA (sotagliflozin) is cost-effective for people with diabetes and recent worsening heartfailure using commonly accepted willingness-to-pay thresholds. “Our healthcare system.
However, information on its efficacy and safety in patients with heartfailure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m 2 was admitted to our hospital for acute heartfailure due to dilated cardiomyopathy. No adverse events were observed during B-SES.
A Seattle-based UW Medicine heartfailure program is keeping patients out of the hospital and providing indefinite care for vulnerable heartfailure patients.
Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices.
For adults with congenital heart disease (ACHD), those with heartfailure (HF) hospitalizations have an increased risk for mortality and morbidity, according to a study published in the Dec. 5 issue of the Journal of the American Heart Association.
(MedPage Today) -- CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heartfailure (HF) hospitalization for this technology.
Background Heartfailure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. In addition, we investigated the beneficial effects of fenofibrate on HF hospitalization. During the 4.22-year
milla1cf Tue, 05/28/2024 - 07:00 May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heartfailure, according to research presented at HeartFailure 2024 , a scientific congress of the European Society of Cardiology (ESC).
Dallas-based UT Southwestern Medical Center researchers found a two-step screening protocol combining clinical risk assessment with biomarker testing that can identify which patients with Type 2 diabetes need medication to prevent heartfailure.
IntroductionThe objective of this study was to examine the impact of ventricular assist device support as a bridge to heart transplantation in children with end-stage heartfailure. The mean length of hospital stay (days) was 214209 in group 1 and 12891 days in group 2.
Breakdown of the study population by worsening heartfailure (WHF) event proportions (oral diuretic intensification or heartfailure [HF] hospitalization) and KaplanMeier curve of all-cause mortality after WHF event shown, relative to a patient group that did not have any WHF events. on log-rank test.
Circulation: HeartFailure, Ahead of Print. Initiatives to reveal asymptomatic gene carriers early in the disease should be encouraged, as it necessitates stringent patient follow-up and immediate treatment onset to reduce the burden of heartfailurehospitalization and mortality in hATTR-CA.
Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heartfailure patient on February 13, 2024 at Henry Ford Hospital in Detroit. She is only the third patient in the U.S. to receive the device.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content